Free Trial

Aligos Therapeutics (ALGS) Institutional Ownership

Aligos Therapeutics logo
$5.76 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$5.93 +0.17 (+2.93%)
As of 05/22/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Aligos Therapeutics (NASDAQ:ALGS)

Current
Institutional Ownership
Percentage
60.43%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$10.19M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$2.95M
Get ALGS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aligos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALGS Institutional Buying and Selling by Quarter

Aligos Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE229,754$1.71M0.0%+1,652.8%3.712%
5/16/2026 SummitTX Capital L.P.148,799$1.11M0.0%+6.7%2.404%
5/14/2026 Renaissance Technologies LLC100,450$746K0.0%+17.6%1.623%
3/17/2026 Rockefeller Capital Management L.P.10,000$93K0.0%+900.0%0.162%
2/18/2026 XTX Topco Ltd23,053$215K0.0%N/A0.375%
2/18/2026 SummitTX Capital L.P.139,424$1.30M0.0%N/A2.267%
2/16/2026 Verition Fund Management LLC71,254$664K0.0%N/A1.159%
2/13/2026 Marshall Wace LLP268,664$2.50M0.0%N/A4.369%
2/12/2026 Jane Street Group LLC24,293$226K0.0%N/A0.395%
2/12/2026 HRT Financial LP11,374$106K0.0%N/A0.185%
2/12/2026 DRW Securities LLC11,950$111K0.0%N/A0.194%
2/12/2026 Renaissance Technologies LLC85,444$796K0.0%+55.3%1.388%
2/11/2026 LPL Financial LLC66,000$615K0.0%+19.7%1.073%
11/17/2025 Woodline Partners LP468,199$4.59M0.0%-9.7%7.613%
11/17/2025 Susquehanna International Group LLP10,107$99K0.0%N/A0.164%
11/17/2025 Citadel Advisors LLC10,310$101K0.0%-32.2%0.168%
11/14/2025 Two Sigma Investments LP38,995$382K0.0%+223.0%0.634%
11/14/2025 Squarepoint Ops LLC30,493$299K0.0%+64.0%0.496%
11/7/2025 Readystate Asset Management LP203,113$1.99M0.1%+48.5%3.303%
11/7/2025Vanguard Group Inc.171,689$1.68M0.0%+22.8%2.792%
10/29/2025 NorthCrest Asset Manangement LLC10,000$98K0.0%N/A0.163%
8/15/2025 Adage Capital Partners GP L.L.C.140,000$1.01M0.0%-69.9%2.291%
8/13/2025 Sio Capital Management LLC335,937$2.42M0.9%+85.9%5.498%
8/12/2025 XTX Topco Ltd13,849$100K0.0%N/A0.227%
8/8/2025 Geode Capital Management LLC34,048$246K0.0%+21.3%0.557%
7/31/2025 AlphaQuest LLC5,943$43K0.0%-62.3%0.097%
5/16/2025Woodline Partners LP315,383$2.60M0.0%N/A5.158%
5/16/2025EcoR1 Capital LLC88,569$731K0.0%-65.3%1.449%
5/16/2025Alyeska Investment Group L.P.412,000$3.40M0.0%N/A6.739%
5/16/2025Adage Capital Partners GP L.L.C.465,000$3.84M0.0%+43.1%7.605%
5/15/2025Trexquant Investment LP38,254$316K0.0%-44.6%0.626%
5/15/2025Heights Capital Management Inc.241,500$1.99M1.0%N/A3.950%
5/14/2025AlphaQuest LLC15,760$130K0.0%N/A0.258%
5/12/2025Vivo Capital LLC10,199$84K0.0%-92.8%0.167%
5/6/2025Readystate Asset Management LP45,400$375K0.0%N/A0.743%
4/23/2025Golden State Wealth Management LLC5,348$44K0.0%+100.0%0.087%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC40,096$1.60M0.1%-40.2%1.117%
2/14/2025Northern Trust Corp5,157$205K0.0%N/A0.144%
2/14/2025Boothbay Fund Management LLC18,543$739K0.0%N/A0.517%
2/14/2025Adage Capital Partners GP L.L.C.325,000$12.95M0.0%+48.5%9.053%
The SpaceX supplier that shipped 5 billion chips to Starlink (Ad)

When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, supplier Broadcom gained 15,000%. The pattern is clear: suppliers often dwarf the headline stock. One little-known company has shipped over 5 billion chips to SpaceX - a figure expected to reach 10 billion by 2027. SpaceX calls them 'instrumental to Starlink's success.' With the IPO expected in June, you can get the name, ticker, and a full year of tech research for just $19 - 85% off.tc pixel

Get the name and ticker before the SpaceX IPO arrives
2/14/2025Tower Research Capital LLC TRC652$26K0.0%+2,073.3%0.018%
2/13/2025Renaissance Technologies LLC11,443$456K0.0%-14.9%0.319%
2/13/2025Wells Fargo & Company MN21,800$869K0.0%N/A0.607%
2/12/2025Trexquant Investment LP69,050$2.75M0.0%N/A1.923%
2/12/2025Geode Capital Management LLC27,253$1.09M0.0%+13.3%0.759%
2/10/2025Avantax Advisory Services Inc.30,570$1.22M0.0%N/A0.852%
2/6/2025Charles Schwab Investment Management Inc.14,286$569K0.0%+19.2%0.398%
1/28/2025Golden State Wealth Management LLC2,674$107K0.0%N/A0.074%
1/22/2025Drive Wealth Management LLC23,000$916K0.2%N/A0.641%
1/21/2025AlphaMark Advisors LLC1,100$44K0.0%+1,000.0%0.031%
11/15/2024Baker BROS. Advisors LP83,055$719K0.0%-96.0%2.599%
11/14/2024Hhlr Advisors LTD.76,247$660K0.0%-97.6%2.383%
11/12/2024Charles Schwab Investment Management Inc.11,980$104K0.0%-61.8%0.374%
8/15/2024Armistice Capital LLC7,256,410$2.54M0.0%+5.3%9.290%
8/9/2024Renaissance Technologies LLC768,839$269K0.0%-4.9%0.984%
8/8/2024Versant Venture Management LLC1,457,937$510K0.7%-37.2%1.867%
8/6/2024Acadian Asset Management LLC829,485$289K0.0%+26.1%1.062%
5/29/2024Opaleye Management Inc.1,630,000$1.60M0.3%+25.7%2.087%
5/10/2024Acadian Asset Management LLC657,995$644K0.0%+17.6%0.870%
2/15/2024Opaleye Management Inc.1,297,000$861K0.2%N/A1.731%
2/14/2024Hhlr Advisors LTD.1,906,191$1.27M0.0%-17.5%2.544%
2/14/2024Altitude Crest Partners Inc.2,844,681$1.89M1.3%N/A3.796%
2/13/2024Armistice Capital LLC6,833,875$4.54M0.1%N/A9.120%
1/1/2024Vanguard Group Inc.1,010,617$755K0.0%+1.6%1.349%
11/14/2023Newtyn Management LLC920,000$687K0.2%+2.2%1.228%
5/15/2023Logos Global Management LP1,000,000$874K0.1%N/A2.329%
5/11/2023Acadian Asset Management LLC564,715$492K0.0%+68.7%1.315%
2/15/2023Tang Capital Management LLC2,816,391$2.68M0.4%+68.2%6.577%
2/10/2023New York Life Investment Management LLC263,832$251K0.0%+12.7%0.616%
11/15/2022Tang Capital Management LLC1,674,166$1.84M0.2%+8.2%3.910%
11/14/2022Point72 Asset Management L.P.917,036$1.01M0.0%+14.6%2.142%
11/14/2022Ergoteles LLC52,889$58K0.0%-49.0%0.124%
11/2/2022Rockefeller Capital Management L.P.77,499$85K0.0%N/A0.181%
8/15/2022Pivotal bioVenture Partners Investment Advisor LLC743,215$899K0.5%-15.2%1.736%
7/25/2022Silverarc Capital Management LLC58,392$71K0.0%+447.8%0.137%
7/18/2022Brinker Capital Investments LLC44,649$54K0.0%N/A0.105%
7/11/2022Wedmont Private Capital20,741$25K0.0%N/A0.049%
5/6/2022IndexIQ Advisors LLC192,976$415K0.0%N/A0.452%
4/19/2022Denali Advisors LLC16,000$34K0.0%N/A0.037%
2/14/2022Virtus ETF Advisers LLC14,209$169K0.1%+108.5%0.033%
2/14/2022Point72 Asset Management L.P.110,488$1.31M0.0%+13.6%0.259%
2/11/2022Ensign Peak Advisors Inc7,320$87K0.0%N/A0.017%
2/8/2022Northern Trust Corp203,799$2.42M0.0%+2.8%0.478%


ALGS Institutional Ownership - Frequently Asked Questions

During the previous two years, 44 institutional investors and hedge funds held shares of Aligos Therapeutics. The most heavily invested institutionals were Woodline Partners LP ($4.59M), Alyeska Investment Group L.P. ($3.40M), Armistice Capital LLC ($2.54M), Marshall Wace LLP ($2.50M), Sio Capital Management LLC ($2.42M), Heights Capital Management Inc. ($1.99M), and Readystate Asset Management LP ($1.99M).Learn more on Aligos Therapeutics' institutional investors.

60.43% of Aligos Therapeutics' stock is owned by institutional investors. Learn more on ALGS's institutional investor holdings.

Of the 37 institutional investors that purchased Aligos Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alyeska Investment Group L.P. ($412K), Armistice Capital LLC ($363K), Opaleye Management Inc. ($333K), Woodline Partners LP ($315.38K), Marshall Wace LLP ($268.66K), Adage Capital Partners GP L.L.C. ($246.19K), and Heights Capital Management Inc. ($241.50K).

Institutional investors have bought a total of 1,173,565 shares in the last 24 months. This purchase volume represents approximately $10.19M in transactions.

The following institutional investors have sold Aligos Therapeutics stock in the last 24 months: Adage Capital Partners GP L.L.C. ($325K), Woodline Partners LP ($50.10K), AlphaQuest LLC ($9.82K), and Citadel Advisors LLC ($4.89K).

Institutional investors have sold a total of 389,806 shares in the last 24 months. This volume of shares sold represents approximately $2.95M in transactions.



This page (NASDAQ:ALGS) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners